Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.

Clinical trial NCT00314210 · COMPLETED

Trial details

NCT number: NCT00314210
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anxiety Disorders

Start date: 2006-03-01
Enrollment: 575

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.